Is intravenous iron supplementation with erythropoiesis-stimulating agents beneficial in cancer patients with anemia?
{{output}}
Chemotherapy-induced anemia is often an important problem for cancer patients, and this complication can be treated with erythropoiesis-stimulating agents (ESAs). This commentary discusses the findings of a study by Bastit et al., in which 396 patients with no... ...
